about
SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in NigeriaSAVVY (C31G) gel for prevention of HIV infection in women: a Phase 3, double-blind, randomized, placebo-controlled trial in Ghana.Comparative safety evaluation of the candidate vaginal microbicide C31GTopical microbicides and HIV prevention in the female genital tractNon-specific microbicide product development: then and nowCervicovaginal safety of the formulated, biguanide-based human immunodeficiency virus type 1 (HIV-1) inhibitor NB325 in a murine modelContraceptive efficacy, acceptability, and safety of C31G and nonoxynol-9 spermicidal gels: a randomized controlled trial.A randomized male tolerance study of dapivirine gel following multiple topical penile exposures (MTN 012/IPM 010).Safety evaluation of 1% tenofovir gel in healthy men.
P2860
Q21144355-EF28CCA9-0E90-4213-8002-8E67D44245BCQ33311277-2753EC90-06A4-41BE-9056-6F75232571C6Q33721949-07231830-8F0C-4513-A3B6-CBD85E5E26B2Q34086820-28C2FD7D-6C44-4688-AAA8-4E7C4E18973CQ35345283-107F866E-313A-48AF-8CF9-3E92F931711AQ35450423-7DBCD803-95B1-43D7-819A-A5D69E6BD30FQ35903730-3009C120-E0E1-46F6-916D-3F71A8F927ADQ37543238-001544F0-ED86-4139-B46E-A9FBBE6123D4Q44947646-7EDA15BF-B992-4138-BC51-1ED5AA856D4A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Male tolerance study of 1% C31G.
@en
type
label
Male tolerance study of 1% C31G.
@en
prefLabel
Male tolerance study of 1% C31G.
@en
P2093
P1433
P1476
Male tolerance study of 1% C31G.
@en
P2093
Christine K Mauck
Marianne M Callahan
Richard Bax
Ron G Frezieres
Susan W Schmitz
Terri L Walsh
P304
P356
10.1016/J.CONTRACEPTION.2003.12.008
P577
2004-09-01T00:00:00Z